The Spine Journal
Volume 2, Issue 1 , Pages 63-69, January 2002

Anterior lumbar interbody fusion with titanium mesh cages, coralline hydroxyapatite, and demineralized bone matrix as part of a circumferential fusion☆☆

  • John S Thalgott, MD

      Affiliations

    • International Spinal Development and Research Foundation, 600 South Rancho Drive, Suite 101, Las Vegas, NV 89106, USA
    • University of Nevada School of Medicine, Manville Building, Reno, NV 89557, USA
    • Corresponding Author InformationCorresponding author. International Spinal Development and Research Foundation, 600 South Rancho Drive, Suite 101, Las Vegas, NV 89106, USA. Tel.: (702) 878-4382; fax: (702) 259-1026.(J.S. Thalgott)
  • ,
  • James M Giuffre, BA

      Affiliations

    • International Spinal Development and Research Foundation, 600 South Rancho Drive, Suite 101, Las Vegas, NV 89106, USA
  • ,
  • Zendek Klezl, MD

      Affiliations

    • Military Medical Academy JEP, PO Box 35, 500 01 Hradec Kralove, Czech Republic and Central Military Hospital Prague, Department of Orthopedics and Traumatology, 169 02 Praha 6, Czech Republic
  • ,
  • Marcus Timlin, M.D.

      Affiliations

    • International Spinal Development and Research Foundation, 600 South Rancho Drive, Suite 101, Las Vegas, NV 89106, USA

Received 28 March 2001; accepted 25 September 2001.

Abstract 

Background context: Anterior lumbar interbody fusion (ALIF) has become one of the primary choices for eliminating motion between vertebral segments in patients with severe discogenic pain and other lumbar pathologies. Autograft is the gold standard for spinal fusion. However, multiple authors have reported complication and morbidity rates associated with iliac crest harvesting to be as high as 25%. Drawbacks to the use of allograft in the anterior column include slower incorporation rates, the possibility for disease transmission, increasing cost resulting from stringent processing and unavailability on a worldwide basis resulting from religious and economic concerns.

Purpose: To determine the clinical and arthrodesis efficacy of coralline hydroxyapatite as an osteoconductive bone graft substitute in the anterior lumbar spine using a titanium mesh cage. Study design: A series of 50 patients returning for long-term prospective follow-up, implanted with titanium mesh cages filled with coralline hydroxyapatite and demineralized bone matrix for ALIF as part of a circumferential fusion.

Patient sample: Long-term clinical and radiographic follow-up were examined for the first 50 patients undergoing this technique by one surgeon. Outcome measures: Pain was measured with a visual analog scale and function was measured with the Oswestry Disability Index. Methods: All 50 patients underwent successful ALIF with titanium mesh cages, coralline hydroxyapatite and demineralized bone matrix, as well as an autologous posterolateral fusion with rigid posterior instrumentation. Patients filled out follow-up questionnaires and appropriate radiographs were taken. Results: A solid fusion rate of 96% was achieved. Mean pain decrease was 60% overall. A total of 70% of all patients either returned to work or to full home activities at a mean of 8 months after surgery. Ninety percent felt the surgery was successful.

Conclusions: The combination of titanium mesh cages, coralline hydroxyapatite and demineralized bone matrix is effective for anterior interbody fusion of the lumbar spine when used as part of a rigidly instrumented circumferential fusion.

Keywords:  Anterior lumbar interbody fusion, Titanium mesh cage, Bone graft substitute, Circumferential fusion

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 FDA device/drug status: Not approved for this indication (MOSS titanium mesh cage); approved for this indication (Pro Osteon 500R).

☆☆ Support in part or in whole was received from DePuy AcroMed.

 Author JST acknowledges a financial relationship (grant research support from and consultant for DePuy AcroMed) which may indirectly relate to the subject of this research.

PII: S1529-9430(01)00155-3

The Spine Journal
Volume 2, Issue 1 , Pages 63-69, January 2002